AquaBounty Technologies (AQB) Projected to Post Earnings on Thursday

AquaBounty Technologies (NASDAQ:AQB) is expected to be releasing its results before the market opens on Thursday, March 26th. Analysts expect AquaBounty Technologies to post earnings of ($0.52) per share and revenue of $0.50 million for the quarter.

AquaBounty Technologies Price Performance

AquaBounty Technologies stock remained flat at $0.91 during midday trading on Wednesday. 17,979 shares of the company traded hands, compared to its average volume of 34,356. The stock has a market capitalization of $3.53 million, a PE ratio of -1.10 and a beta of 1.29. The firm has a 50 day moving average price of $0.94 and a two-hundred day moving average price of $1.14. AquaBounty Technologies has a twelve month low of $0.60 and a twelve month high of $2.95.

Hedge Funds Weigh In On AquaBounty Technologies

A hedge fund recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP acquired a new stake in AquaBounty Technologies, Inc. (NASDAQ:AQB) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned about 0.97% of AquaBounty Technologies as of its most recent SEC filing. 8.92% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of AquaBounty Technologies in a report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.